U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2NO3.Ni.6H2O
Molecular Weight 290.7949
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NICKEL NITRATE HEXAHYDRATE

SMILES

O.O.O.O.O.O.[Ni++].[O-][N+]([O-])=O.[O-][N+]([O-])=O

InChI

InChIKey=AOPCKOPZYFFEDA-UHFFFAOYSA-N
InChI=1S/2NO3.Ni.6H2O/c2*2-1(3)4;;;;;;;/h;;;6*1H2/q2*-1;+2;;;;;;

HIDE SMILES / InChI

Molecular Formula NO3
Molecular Weight 62.0049
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Ni
Molecular Weight 58.6934
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.cdc.gov/niosh/docs/81-123/pdfs/0445.pdf

Nickel nitrate is the inorganic compound Ni(NO3)2. The most common form of nickel nitrate is hexahydrate. It is irritating to the eyes, skin and, upon inhalation of the dust, respiratory tract. It may cause skin allergy. Along with most other nickel compounds, nickel nitrate is a carcinogen. Nickel(II) nitrate hexahydrate is widely used in the production of nickel catalysts, by impregnating an inert carrier and decomposing the nitrate.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Mutagenicity tests with nickel salts in the male mouse.
1982
Zinc, cadmium and nickel increase the activation of NF-κB and the release of cytokines from THP-1 monocytic cells.
2011 Nov
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: The Ni compounds used in this experiment were nickel metal [Ni-M], nickel oxide (green) [NiO(G)], nickel oxide (black) [NiO(B)], nickel subsulfide [Ni3S2], nickel sulfide [NiS], nickel sulfate [NiSO4], nickel chloride [NiCl2], and nickel nitrate [Ni(NO3)2]. The solubilities of the nickel compounds in saline solution were in the following order; [Ni(NO3)2 > NiCl2 > NiSO4] >> [NiS > Ni3S2] > [NiO(B) > Ni-M > NiO(G)]. The Ni level in the visceral organs was higher in the rats given soluble Ni compounds; Ni(NO3)2, NiCl2, NiSO4, than that in the rats receiving other compounds. In the rats to which soluble Ni compounds were administered, 80-90% of the recovered Ni amounts in the examined organs was detected in the kidneys.
Distribution of various nickel compounds in rat organs
Route of Administration: Oral
Human stratum corneum (SC) was prepared by trypsinization of dermatomed cadaver leg skin. The diffusion system included diffusion cells with a spiral line. Aqueous solutions of nickel salts (Ni(NO3)2, NiSO4, NiCl2 and Ni(-OOCCH3)2 at 1% Ni2+ concentration) were used as the donor solution (400 microL/cell). The receptor fluid, pure water, was collected up to 96 h after application of the donor solutions. Nickel concentrations in the donor and receptor fluid, as well as in the SC, were analysed using inductively coupled plasma mass spectrometry (ICP-MS) with a confidence limit of 0.5 ppb. Based on the total recovery of nickel from the experiments, about 98% of the dose remained in the donor solution, whereas 1% or less was retained in SC and less than 1% was found in the receptor fluid. Following an early surge, nickel permeates slowly across SC. The steady-state permeability coefficients of nickel were calculated from the flux data (approximately 5.2-8.5 x 10(-7) cm/h) with no significant difference among the salts. The results concur in principle with earlier studies conducted using the full-thickness human skin in vitro, and suggest that in vivo nickel ions may permeate simultaneously by routes of diffusion such as the shunt pathway, apart from slow transcellular/intercellular diffusion alone.
Substance Class Chemical
Created
by admin
on Sat Dec 16 04:01:54 GMT 2023
Edited
by admin
on Sat Dec 16 04:01:54 GMT 2023
Record UNII
XBT61WLT1J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NICKEL NITRATE HEXAHYDRATE
MI  
Systematic Name English
NICKELOUS NITRATE HEXAHYDRATE
Common Name English
NICKEL(II) NITRATE, HEXAHYDRATE (1:2:6)
Common Name English
NICKEL NITRATE (NI(NO3)2) HYDRATE (1:6)
Common Name English
NICKEL(2+) BIS(NITRATE) HEXAHYDRATE
Systematic Name English
NITRIC ACID NICKEL(2+) SALT (2:1) HEXAHYDRATE
Common Name English
NITRIC ACID, NICKEL(2+) SALT, HEXAHYDRATE
Common Name English
NICKEL NITRATE HEXAHYDRATE [MI]
Common Name English
Code System Code Type Description
MERCK INDEX
m7868
Created by admin on Sat Dec 16 04:01:54 GMT 2023 , Edited by admin on Sat Dec 16 04:01:54 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID70158941
Created by admin on Sat Dec 16 04:01:54 GMT 2023 , Edited by admin on Sat Dec 16 04:01:54 GMT 2023
PRIMARY
FDA UNII
XBT61WLT1J
Created by admin on Sat Dec 16 04:01:54 GMT 2023 , Edited by admin on Sat Dec 16 04:01:54 GMT 2023
PRIMARY
PUBCHEM
61630
Created by admin on Sat Dec 16 04:01:54 GMT 2023 , Edited by admin on Sat Dec 16 04:01:54 GMT 2023
PRIMARY
CAS
13478-00-7
Created by admin on Sat Dec 16 04:01:54 GMT 2023 , Edited by admin on Sat Dec 16 04:01:54 GMT 2023
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE